A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Conditions
Solid Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic Hospital, Phoenix, Arizona, United States
Stanford University, Palo Alto, California, United States
UCLA Healthcare Hematology-Oncology, Santa Monica, California, United States
Sarah Cannon Research Institue At Healthone, Denver, Colorado, United States
Mayo Clinic Florida, Jacksonville, Florida, United States
Florida Cancer Specialists, Sarasota, Florida, United States
Florida Cancer Specialists, Sarasota, Florida, United States
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore, Maryland, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
Weill Cornell Medicine, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Jefferson University Hospitals, Philadelphia, Pennsylvania, United States
Scri Oncology Partners, Nashville, Tennessee, United States
Md Anderson Cancer Center, Houston, Texas, United States
Chris Obrien Lifehouse, Camperdown, New South Wales, Australia
St Vincent'S Hospital Sydney, Darlinghurst, New South Wales, Australia
Peter Maccallum Cancer Centre, Melbourne, Victoria, Australia
The Alfred Hospital, Melbourne, Victoria, Australia
Linear Clinical Research, Nedlands, Western Australia, Australia
Cliniques Universitaires Ucl Saint-Luc, Brussels, Belgium
Universitair Ziekenhuis Antwerpen (Uza), Edegem, Belgium
Universitair Ziekenhuis (Uz) Leuven, Leuven, Belgium
The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada
Princess Margaret Cancer Center, Toronto, Ontario, Canada
Centre Leon Berard, Lyon, France
Universitaire Du Cancer de Toulouse Institut Claudius Regaud Iuct-Oncopole, Toulouse, France
Institut Gustave Roussy, Villejuif, France
Fondazione Irccs Istituto Nazionale Dei Tumori, Milan, Italy
Irccs Istituto Clinico Humanitas, Rozzano, Italy
Centro Ricerche Cliniche Di Verona, Verona, Italy
National Cancer Center Hospital East, Chiba, Japan
The Cancer Institute Hospital of Jfcr, Tokyo, Japan
Hospital General Universitario Vall D Hebron, Barcelona, Spain
Fundacion Jimenez Diaz, Madrid, Spain
Hospital Universitario Quironsalud Madrid, Madrid, Spain
Study leads
Incyte Medical Monitor
Study Director
Incyte Corporation